{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:46:21Z","timestamp":1774017981795,"version":"3.50.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,15]]},"DOI":"10.2146\/ajhp160262","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T18:05:16Z","timestamp":1499450716000},"page":"1062-1066","source":"Crossref","is-referenced-by-count":7,"title":["Hyponatremia induced by hyperinsulinemia\u2013euglycemia therapy"],"prefix":"10.1093","volume":"74","author":[{"given":"Jennifer R.","family":"Beavers","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna L.","family":"Stollings","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd W.","family":"Rice","sequence":"additional","affiliation":[{"name":"Division of Allergy\/Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041103313477700_b1-0741062","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3109\/15563650.2014.987397","article-title":"2013 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 31st annual report","volume":"52","author":"Mowry","year":"2014","journal-title":"Clin Toxicol."},{"key":"key\n\t\t\t\t2019041103313477700_b2-0741062","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.2146\/ajhp060041","article-title":"Treatment of poisoning caused by \u03b2-adrenergic and calcium-channel blockers","volume":"63","author":"Sheperd","year":"2006","journal-title":"Am J Health-Syst Pharm."},{"key":"key\n\t\t\t\t2019041103313477700_b3-0741062","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1081\/CLT-120023761","article-title":"Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review","volume":"41","author":"Bailey","year":"2003","journal-title":"J Toxicol Clin Toxicol."},{"key":"key\n\t\t\t\t2019041103313477700_b4-0741062","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/15563650500394795","article-title":"A comparison of vasopressin and glucagon in beta-blocker induced toxicity","volume":"44","author":"Holger","year":"2006","journal-title":"Clin Toxicol."},{"key":"key\n\t\t\t\t2019041103313477700_b5-0741062","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3109\/15563650.2014.965827","article-title":"Treatment for calcium channel blocker poisoning: a systematic review","volume":"52","author":"St-Onge","year":"2014","journal-title":"Clin Toxicol."},{"key":"key\n\t\t\t\t2019041103313477700_b6-0741062","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.emc.2007.02.001","article-title":"Management of \u03b2-adrenergic blocker and calcium channel antagonist toxicity","volume":"25","author":"Kerns","year":"2007","journal-title":"Emerg Med Clin North Am."},{"key":"key\n\t\t\t\t2019041103313477700_b7-0741062","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00006565-200202000-00012","article-title":"Hyperinsulinemia\/euglycemia therapy for calcium channel blocker poisoning","volume":"18","author":"Boyer","year":"2002","journal-title":"Pediatr Emerg Care."},{"key":"key\n\t\t\t\t2019041103313477700_b8-0741062","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJM200105313442215","article-title":"Treatment of calcium-channel-blocker intoxication with insulin infusion","volume":"344","author":"Boyer","year":"2001","journal-title":"N Engl J Med."},{"key":"key\n\t\t\t\t2019041103313477700_b9-0741062","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0300-9572(03)00026-1","article-title":"Treatment of calcium channel blocker intoxication with insulin infusion","volume":"57","author":"Marques","year":"2003","journal-title":"Resuscitation."},{"key":"key\n\t\t\t\t2019041103313477700_b10-0741062","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1034\/j.1399-6576.2003.00181.x","article-title":"Severe intoxication after an intentional overdose of amlodipine","volume":"47","author":"Rasmussen","year":"2003","journal-title":"Acta Anaesthesiol Scand."},{"key":"key\n\t\t\t\t2019041103313477700_b11-0741062","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1056\/NEJMcpc069016","article-title":"Case records of the Massachusetts General Hospital. Case 24-2006. A 40-year-old woman with hypotension after an overdose of amlodipine","volume":"355","author":"Harris","year":"2006","journal-title":"N Engl J Med."},{"key":"key\n\t\t\t\t2019041103313477700_b12-0741062","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-007-0768-y","article-title":"Relative safety of hyperinsulinaemia\/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study","volume":"33","author":"Greene","year":"2007","journal-title":"Intensive Care Med."},{"key":"key\n\t\t\t\t2019041103313477700_b13-0741062","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/15563650.2011.582471","article-title":"High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning","volume":"49","author":"Engebretsen","year":"2011","journal-title":"Clin Toxicol."},{"key":"key\n\t\t\t\t2019041103313477700_b14-0741062","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra1404489","article-title":"Disorders of plasma sodium\u2014causes, consequences, and correction","volume":"372","author":"Ingelfinger","year":"2015","journal-title":"N Engl J Med."},{"key":"key\n\t\t\t\t2019041103313477700_b15-0741062","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.HYP.0000184541.24700.c7","article-title":"Calcium antagonists: effects on cardio-renal risk in hypertensive patients","volume":"46","author":"Sandeep","year":"2005","journal-title":"Hypertension."},{"key":"key\n\t\t\t\t2019041103313477700_b16-0741062","article-title":"Calcium channel blockers (chapter 61)","volume-title":"Goldfrank\u2019s toxicologic emergencies","author":"Jang","year":"2011","edition":"9e"},{"key":"key\n\t\t\t\t2019041103313477700_b17-0741062","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.01.2012.5643","article-title":"Life-threatening calcium channel blocker overdose and its management","volume":"2012","author":"Rizvi","year":"2012","journal-title":"BMJ Case Rep"},{"key":"key\n\t\t\t\t2019041103313477700_b18-0741062","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00139709-200423040-00003","article-title":"Pharmacology, pathophysiology and management of calcium channel blocker and \u03b2-blocker toxicity","volume":"23","author":"DeWitt","year":"2004","journal-title":"Toxicol Rev."},{"key":"key\n\t\t\t\t2019041103313477700_b19-0741062","article-title":"Beta-adrenergic antagonists (chapter 62)","volume-title":"Goldfrank\u2019s toxicologic emergencies","author":"Jang","year":"2011","edition":"9e"},{"key":"key\n\t\t\t\t2019041103313477700_b20-0741062","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(83)80356-8","article-title":"Profound hyperglycemia and metabolic acidosis after verapamil overdose","volume":"2","author":"Enyeart","year":"1983","journal-title":"J Am Coll Cardiol."},{"key":"key\n\t\t\t\t2019041103313477700_b21-0741062","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-3565(25)39488-7","article-title":"Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine","volume":"267","author":"Kline","year":"1993","journal-title":"J Pharmacol Exp Ther."},{"key":"key\n\t\t\t\t2019041103313477700_b22-0741062","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00005344-199605000-00015","article-title":"Myocardial metabolism during graded intraportal verapamil infusion in awake dogs","volume":"27","author":"Kline","year":"1996","journal-title":"J Cardiovasc Pharmacol."},{"key":"key\n\t\t\t\t2019041103313477700_b23-0741062","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/00003246-199507000-00016","article-title":"Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine","volume":"23","author":"Kline","year":"1995","journal-title":"Crit Care Med."},{"key":"key\n\t\t\t\t2019041103313477700_b24-0741062","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0196-0644(97)70196-3","article-title":"Insulin improves survival in a canine model of acute beta-blocker toxicity","volume":"29","author":"Kerns","year":"1997","journal-title":"Ann Emerg Med."},{"key":"key\n\t\t\t\t2019041103313477700_b25-0741062","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03161225","article-title":"The use of high-dose insulin-glucose euglycemia in beta-blocker overdose: a case report","volume":"5","author":"Page","year":"2009","journal-title":"J Med Toxicol."},{"key":"key\n\t\t\t\t2019041103313477700_b26-0741062","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1081\/CLT-100102437","article-title":"Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning","volume":"37","author":"Yuan","year":"1999","journal-title":"J Toxicol Clin Toxicol."},{"key":"key\n\t\t\t\t2019041103313477700_b27-0741062","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0884533608314531","article-title":"Nutrition-focused evaluation and management of dysnatremias","volume":"23","author":"Whitmire","year":"2008","journal-title":"Nutr Clin Pract."},{"key":"key\n\t\t\t\t2019041103313477700_b28-0741062","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/74\/14\/1062\/28336215\/ajhp1062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T15:18:26Z","timestamp":1750519106000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/74\/14\/1062\/5102560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,15]]},"references-count":28,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,7,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp160262","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,15]]},"published":{"date-parts":[[2017,7,15]]}}}